Home
Home Page
Recent Posts
Top Active Boards
Popular Posts
Biotech Tweets
Market Tweets
Energy Industry Tweets
Official IV Sponsor Page
My Content
My Boards
My Feed
My Library
My Links
Boards Search
Groups Directory
My Network
My Favorite Posters
My Private Message Groups
My Blocked Sender List
Member Directory
Account
Email & Password
Subscription/Membership
All Account Details
My Profile
My Device Info
Sign Up
Settings
My Site Settings
My Notification Settings
BOARDS
Sign In for Filters
|
BOARDS
Become a Member
|
Sign In
Advertise With Us
Board Stats
:
329 members / 2125 guests [742]
Bristol-Myers Squibb Co.
Watch this video to learn more about IV Lite
The Perfect Plan for Lurkers
Board
Links
(more...)
Y!
CELG MM R&D deep dive
CELG legacy IV board (still active)
CELG legacy IV board (premium)
@bmsnews (Company Twitter Account)
GoFundMe Mike Barnett Recovery Fund
BMY / Message Board
BOARD
GROUPS
Loading...
Written By
On Topic Only
--
All Messages
Hide Replies
Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
Go to Msg #
MSG #
SUBJECT
TYPE
AUTHOR
SENTIMENT
RECS
DATE POSTED
9707
Bristol Myers Squibb Data at ASCO and EHA 2022 Highlight Progress in Transforming Treatment for Patients with Cancer and Blood Disorders
GN
Biotech2050
1
5/19/2022 7:03:32 AM
9706
OT - how to explain “Freudian slip” to non native speakers
GN
Biotech2050
0
5/19/2022 1:04:22 AM
9705
Building IP: BMY Patent APplication re "ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF"
GN
JBWIN
0
5/19/2022 1:02:13 AM
9704
Building IP: BMY Patent Application re "CYTOKINE PROFILING ANALYSIS"
GN
JBWIN
0
5/19/2022 1:00:45 AM
9703
Building IP: Celgene Quanticel Research Patent Application re "INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1"
GN
JBWIN
0
5/19/2022 12:59:34 AM
9702
Re: OT - CSCO reality check
GN
JBWIN
0
5/18/2022 6:04:36 PM
9701
Re: Are we done with ASR?
GN
JBWIN
2
5/18/2022 5:54:37 PM
9700
Are we done with ASR?
GN
teflon2000
0
5/18/2022 5:12:42 PM
9699
OT - CSCO reality check
GN
Biotech2050
0
5/18/2022 4:10:45 PM
9698
Re: Interesting Immatics release on expansion of Opdivo combo expansion treating a variety of solid tumors. - see News. EOM.
GN
JBWIN
5
5/18/2022 8:53:02 AM
Go to Msg #
About Us
•
Contact Us
•
Follow Us on Twitter
•
Members Directory
•
Help Center
•
Advertise
•
Official IV Sponsor Page
Become a Patron
© 2003-2022 Investorvillage.com. All rights reserved.
User Agreement
Financial Market Data provided by
.
Loading...